Cognition Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cognition Therapeutics (CGTX).

Price Target Range — 9 Quarters

Analyst Consensus — 6 Analysts

5Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$6Upside to Avg. PT+656.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Mar 27, 2026	Chardan Capital	Daniil Gataulin	Maintained	Buy	$4
Dec 4, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$3
Nov 21, 2025	B. Riley Securities	William Woods	PT Raise	Buy	$2→$3
Nov 19, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$3
Aug 8, 2025	Chardan Capital	Daniil Gataulin	Maintained	Buy	$4
Jun 26, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$3
May 27, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$5→$3
May 8, 2025	Chardan Capital	Daniil Gataulin	PT Cut	Buy	$8→$4
Mar 24, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$6→$5
Mar 21, 2025	Chardan Capital	Daniil Gataulin	PT Cut	Buy	$11→$8
Feb 26, 2025	Chardan Capital	Daniil Gataulin	Maintained	Buy	$11
Dec 19, 2024	B. Riley Securities	Mayank Mamtani	Upgrade	Neutral→Buy	$1→$2
Dec 19, 2024	Chardan Capital	Daniil Gataulin	Maintained	Buy	$11
Dec 19, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$5→$6
Nov 27, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$5
Nov 15, 2024	Chardan Capital	Daniil Gataulin	Maintained	Buy	$11
Nov 4, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$5
Oct 31, 2024	Chardan Capital	Daniil Gataulin	Maintained	Buy	$11
Aug 12, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$7→$5
Aug 6, 2024	B. Riley Securities	Mayank Mamtani	Downgrade	Buy→Neutral	$5→$1

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and maintains $3 price target.

Benzinga Newsdesk

PRO
B. Riley Securities Reiterates Buy on Cognition Therapeutics, Raises Price Target to $3

B. Riley Securities analyst William Woods reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and raises the price target from $2 to $3.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and maintains $3 price target.

Benzinga Newsdesk

PRO
Chardan Capital Maintains Buy on Cognition Therapeutics, Maintains $4 Price Target

Chardan Capital analyst Daniil Gataulin maintains Cognition Therapeutics (NASDAQ:CGTX) with a Buy and maintains $4 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and maintains $3 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics (NASDAQ:CGTX) with a Buy and lowers the price target from $5 to $3.

Benzinga Newsdesk

Cognition Therapeutics Inc

Cognition Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PRO
B. Riley Securities Reiterates Buy on Cognition Therapeutics, Raises Price Target to $3

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PRO
Chardan Capital Maintains Buy on Cognition Therapeutics, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3

People Also Watch

People Also Watch

Cognition Therapeutics Inc

Cognition Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PROB. Riley Securities Reiterates Buy on Cognition Therapeutics, Raises Price Target to $3

PROHC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PROChardan Capital Maintains Buy on Cognition Therapeutics, Maintains $4 Price Target

PROHC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PROHC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PRO
B. Riley Securities Reiterates Buy on Cognition Therapeutics, Raises Price Target to $3

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PRO
Chardan Capital Maintains Buy on Cognition Therapeutics, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3